A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis

American Journal of Pathology

Volumn 169, Issue 3, 2006, Pages 861-876

  Ruddell, Richard G ^a,b   Oakley, Fiona ^a   Hussain, Ziafat ^a   Yeung, Irene ^a   Bryan Lluka, Lesley J ^c   Ramm, Grant A ^b   Mann, Derek A ^a,d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; LIVER FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL;

EID: 33748798900     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050767     Document Type: Article

References (54)

1. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000, 275:2247-2250
2. Mann DA, Smart DE: Transcriptional regulation of hepatic stellate cell activation. Gut 2002, 50:891-896
3. Battaler R, Brenner DA: Liver fibrosis. J Clin Invest 2005, 115:209-218
4. Murphy FR, Issa R, Zhou X, Ratnaraja S, Nagase H, Arthur MJ, Benyon RC, Iredale JP: Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinases-1 is mediated via effects on matrix metalloproteinase inhibition. J Biol Chem 2002, 277:11069-11076
5. Oakley F, Meso M, Iredale JP, Green K, Marek CJ, Zhou X, May MJ, Millward-Sadler H, Wright MC, Mann DA: Inhibition of inhibitor of κB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 2005, 128:108-120
6. Benyon RC, Arthur MJ: Extracellular matrix degradation and the role of hepatic stellate cells. Semin Liver Dis 2001, 21:373-384
7. Borkham-Kamphorst E, Herrmann J, Stoll D, Treptau J, Gressner A, Weiskirchen R: Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis. Lab Invest 2004, 766-777
8. Wright MC, Issa R, Smart DE, Trim N, Murray GI, Primrose JN, Arthur MJ, Iredale JP, Mann DA: Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances resolution of liver fibrosis in rats. Gastroenterology 2001, 121:685-698
9. Dekel R, Zvibel I, Brill S, Brazovsky E, Halpern Z, Oren R: Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model. Dig Dis Sci 2003, 48:1642-1647
10. Scharf JG, Dombrowski F, Novosyadlyy R, Eisenbach C, Demori I, Kubler B, Braulke T: Insulin-like growth factor (IGF) binding protein-1 is highly induced during acute carbon tetrachloride liver injury and potentiates the IGF-I-stimulated activation of rat hepatic stellate cells. Endocrinology 2004, 145:3463-3472
11. Rachfal AW, Brigstock DR: Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatol Res 2003, 26:1-9
12. Wong L, Yamasaki G, Johnson RJ, Freidman SL: Induction of beta-platelet-derived growth factor receptor in hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994, 94:1563-1569
13. Pinzani M: PDGF and signal transduction in hepatic stellate cells. Front Biosci 2002, 7:d1720-d1726
14. Oakley F, Trim N, Constandinou CM, Ye W, Gray AM, Frantz G, Hillan K, Kendall T, Benyon RC, Mann DA, Iredale JP: Hepatocytes express nerve growth factor during liver injury. Am J Pathol 2003, 163:1849-1858
15. Saile B, Matthes N, Knittel T, Ramadori G: Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 1999, 30:196-202
16. Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S: Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 2005, 128:742-755
17. Tamir P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ: Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 2003, 37:87-95
18. Gong W, Pecci A, Lahme B, Beato M, Gressner AM: Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998, 28:492-502
19. Hoyer D, Hannon JP, Martin GR: Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002, 71:533-554
20. 2 "receptosomes." Biol Cell 2004, 96:373-381
21. Roth BL, Willins DL, Kristiansen K, Kroeze WK: 5-Hydroxytrptamine2-family receptors (5-hydroxytrptamine2A, 5-hydroxytrptamine2B, 5-hydroxytrptamine2C): where structure meets function. Pharmacol Ther 1998, 79:231-257
22. Kent JM: SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Lancet 2000, 355:911-918
23. 2A receptor induces TGF-beta1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am J Physiol 1999, 276:F922-F930
24. Hahn A, Heusinger-Ribeiro J, Lanz T, Zenkel S, Goppelt-Struebe M: Induction of connective tissue growth factor by activation of heptahelical receptors: modulation by Rho proteins and the actin cytoskeleton. J Biol Chem 2000, 275:35429-35435
25. Bryan-Lluka LJ, Papacostas MH, Paczkowski FA, Wanstall JC: Nitric oxide donors inhibit 5-hydroxytyptamine (5-HT) uptake by the human 5-HT transporter (SERT). Br J Pharmacol 2004, 143:63-70
26. 2 receptor antagonist. J Dermatol 2000, 27:643-650
27. Akhondzadeh S, Mohajari H, Reza Mohammadi M, Amini H: Ritanserin as an adjunct to lithium and haloperidol for the treatment of medication-naïve patients with acute mania: a double blind and placebo controlled trial. BMC Psychiatry 2003, 3:7
28. Borawski J, Mazerska M, Rydzewski A, Pawlak K, Rowinski M, Mysliwiec M: Ketanserin: a new perspective in posttransplant erythrocytosis? Clin Transplant 1996, 10:63-66
29. 2B receptors. Int J Dev Neurosci 2001, 19:365-372
30. Sakai D, Murakami M, Kawazoe K, Tsutsumi Y: Heal carcinoid tumor complicating carcinoid heart disease and secondary retroperitoneal fibrosis. Pathol Int 2000, 50:404-411
31. Balasubramanian S, Paulose CS: Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor. Hepatology 1998, 27:62-66
32. Marzioni M, Glaser S, Francis H, Marucci L, Benedetti A, Alvaro D, Taffetani S, Ueno Y, Roskams T, Phinizy JL, Venter J, Fava G, Lesage GD, Alpini G: Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology 2005, 128:121-137
33. 2-receptor blockade on serotonin-induced intralobular hypoperfusion. Int J Microcicrc Clin Exp 1993, 13:99-112
34. Beaudry P, Hadengue A, Callebert J, Gaudin C, Soliman H, Moreau R, Launay JM, Lebrec D: Blood and plasma 5-hydroxytryptamine levels in patients with cirrhosis. Hepatology 1994, 20:800-803
35. Laffi G, Marra F, Gresele P, Romagnoli P, Palermo A, Bartolini O, Simoni A, Orlandi L, Selli ML, Nenci GG: Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992, 103:641-646
36. Marasini B, Biondi ML, Agostoni A: Platelet and plasma serotonin in patients with liver cirrhosis. J Clin Chem Clin Biochem 1989, 27:419-421
37. Stoyanova II: Relevance of mast cells and hepatic lobule innervation to liver injury. Rom J Gastroenterol 2004, 13:203-209
38. Hsu CT: The role of the autonomic nervous system in chemically-induced liver damage and repair using the essential hypertensive animal model (SHR). J Auton Nerv Syst 1995, 51:135-142
39. Lambert HW, Weiss ER, Lauder JM: Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-1 in cultured craniofacial mesenchymal cells. Dev Neurosci 2001, 23:70-77
40. Kasho M, Sakai M, Sasahara T, Anami Y, Matsumura T, Takemura T, Matsuda H, Kobori S, Shichiri M: Serotonin enhances the production of type IV collagen by human mesangial cells. Kidney Int 1998, 54:1083-1092
41. Passaretti TV, Wilcox BD, Jeffrey JJ: Serotonin regulation of gene expression in uterine extracellular matrix: reciprocal effects on collagens and oollagenase. Mol Cell Endocrinol 1996, 120:125-132
42. 2A receptor induces TGF-b1 expression in mesangial cells via ERK: proliferative and fibrotic signals. Am J Physiol 1999, 276:F922-F930
43. Jian B, Xu J, Connolly J, Ravani RC, Narula N, Liang B, Levy R: Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-b1 via G-protein signal transduction in aortic valve interstitial cells. Am J Path 2002, 161:2111-2121
44. Eto Y, Nitta K, Uchida K, Tsutsui T, Natori K, Kawahima A, Yumura W, Nihei H: Anti-mitogenic effects of sarpogrelate in cultured rat mesangial cells. Life Sci 1997, 60:193-199
45. Nebigil CG, Launay J-M, Hickel P, Tournois C, Maroteaux L: 5-Hydroxytyptamine 2B receptor regulates cell-cycle progression: cross talk with tyrosine kinase pathways. Proc Natl Acad Sci USA 2000, 97:2591-2596
46. Gentilini A, Marra F, Gentilini P, Pinzani M: Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. J Hepatol 2000, 32:227-234
47. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD: Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993, 90:2542-2546
48. Chang AS, Chang SM, Starnes DM, Schroeter S, Bauman AL, Blakely RD: Cloning and expression of the mouse serotonin transporter. Brain Res Mol Brain Res 1996, 43:185-192
49. Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, Bradley CC: Cloning and expression of a functional serotonin transporter from rat brain. Nature 1991, 353:66-70
50. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S: Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ Res 1999, 84:329-336
51. Kubota N, Kiuchi Y, Nemoto M, Oyamada H, Ohno M, Funahashi H, Shioda S, Oguchi K: Regulation of serotonin transporter gene expression in human glial cells by growth factors. Eur J Pharmacol 2001, 417:69-76
52. Pizzinat N, Girolami JP, Parini A, Pacher C, Ordener C: Serotonin metabolism in rat mesangial cells: involvement of serotonin transporter and monoamine oxidase A. Kidney Int 1999, 56:1391-1399
53. 2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 1997, 124:1745-1755
54. 2B receptor signalling. FASEB J 2003, 17:1373-1375